[go: up one dir, main page]

MA26505A1 - 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
MA26505A1
MA26505A1 MA25105A MA25105A MA26505A1 MA 26505 A1 MA26505 A1 MA 26505A1 MA 25105 A MA25105 A MA 25105A MA 25105 A MA25105 A MA 25105A MA 26505 A1 MA26505 A1 MA 26505A1
Authority
MA
Morocco
Prior art keywords
methylerythromycin
derivatives
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
MA25105A
Other languages
French (fr)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26505A1 publication Critical patent/MA26505A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MA25105A 1997-06-11 1998-06-10 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MA26505A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
MA26505A1 true MA26505A1 (en) 2004-12-20

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25105A MA26505A1 (en) 1997-06-11 1998-06-10 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
ATE298761T1 (en) 1998-09-22 2005-07-15 Pfizer Prod Inc CARBAMAT AND CARBAZATE KETOLID ANTIBIOTICS
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
DE60030847T2 (en) * 1999-04-16 2007-04-19 Kosan Biosciences, Inc., Hayward ANTI-INFECTIOUS MAKROLIDE DERIVATIVES
CN1351608A (en) 1999-05-24 2002-05-29 辉瑞产品公司 13-Methylerythromycin Derivatives
WO2000075156A1 (en) * 1999-06-07 2000-12-14 Abbott Laboratories 6-o-carbamate ketolide derivatives
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
WO2004080391A2 (en) * 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102245195B (en) 2008-10-24 2016-01-13 森普拉制药公司 Biodefense using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (en) 2009-09-10 2018-06-01 森普拉制药公司 Methods of treating malaria, tuberculosis and MAC disease
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
PL2550286T3 (en) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (en) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド Hydrogen bond forming fluoroketolides for disease treatment
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
RU2015138796A (en) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. METHODS AND COMPOSITIONS FOR TREATMENT OF RESPIRATORY DISEASES
HK1218864A1 (en) 2013-03-15 2017-03-17 森普拉制药公司 Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
HN1998000073A (en) 1999-01-08
NO996108D0 (en) 1999-12-10
PA8451801A1 (en) 2000-05-24
TW448174B (en) 2001-08-01
JP2000513026A (en) 2000-10-03
TNSN98083A1 (en) 2005-03-15
AR012244A1 (en) 2000-09-27
HRP980316A2 (en) 1999-04-30
BR9810021A (en) 2000-09-19
EA199901016A1 (en) 2000-06-26
NO996108L (en) 2000-02-10
CO4940506A1 (en) 2000-07-24
AP9801253A0 (en) 1999-12-04
KR20010013660A (en) 2001-02-26
WO1998056800A1 (en) 1998-12-17
ID24529A (en) 2000-07-20
IL132767A0 (en) 2001-03-19
OA11225A (en) 2003-07-17
AU7226798A (en) 1998-12-30
GT199800074A (en) 1999-11-27
CN1259135A (en) 2000-07-05
HUP0002252A2 (en) 2000-12-28
CA2293335A1 (en) 1998-12-17
BG103947A (en) 2000-07-31
HUP0002252A3 (en) 2002-01-28
CZ9904388A3 (en) 2002-10-16
ZA985018B (en) 1999-12-10
PL337606A1 (en) 2000-08-28
PE79899A1 (en) 1999-08-25
TR199902995T2 (en) 2000-02-21
IS5251A (en) 1999-11-16
EP0988308A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
MA26505A1 (en) 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26472A1 (en) N-HYDROXY-B-SULFONYLPROPIONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26479A1 (en) NICOTINAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26468A1 (en) SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26424A1 (en) 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26433A1 (en) PYRIDYLPYRROLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26558A1 (en) NOVEL 6-0-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2735777B1 (en) 4-PHENYLAMINOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2780057B1 (en) PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26680A1 (en) NEW ALCYNYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26499A1 (en) TETRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26687A1 (en) 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROQUINOLEINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26686A1 (en) NOVEL 4,4-BIARYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26425A1 (en) LACTAM DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2740136B1 (en) INDOLIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26559A1 (en) D-PROLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
MA26432A1 (en) DERIVATIVES OF 2- (2-OXO-ETHYLIDENE) -IMIDAZOLIDINE-4-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26465A1 (en) NEW QUINOLEIN DERIVATIVES AND QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26471A1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26414A1 (en) NEW QUINOLEINE AND QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM.
MA26638A1 (en) NOVEL ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26438A1 (en) SUBSTITUTED 6,5-HETEROBICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26624A1 (en) NEW QUINAZOLINAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26519A1 (en) AZETIDINYLPROPYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2751334B1 (en) SYNTHETIC POLYSACCHARIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM